BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 30060554)

  • 41. Contribution of the Mucosal Microbiota to Bovine Respiratory Health.
    Zeineldin M; Lowe J; Aldridge B
    Trends Microbiol; 2019 Sep; 27(9):753-770. PubMed ID: 31104970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gut microbiota imbalance and colorectal cancer.
    Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M
    World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drosophila as a model for intestinal dysbiosis and chronic inflammatory diseases.
    Lee KA; Lee WJ
    Dev Comp Immunol; 2014 Jan; 42(1):102-10. PubMed ID: 23685204
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Host-Microbiota Interaction and Intestinal Epithelial Functions under Circadian Control: Implications in Colitis and Metabolic Disorders.
    Huang YJ; Pai YC; Yu LC
    Chin J Physiol; 2018 Dec; 61(6):325-340. PubMed ID: 30580502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential Role of the Lung Microbiome in Shaping Asthma Phenotypes.
    Chung KF
    Ann Am Thorac Soc; 2017 Nov; 14(Supplement_5):S326-S331. PubMed ID: 29161086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease.
    O'Dwyer DN; Dickson RP; Moore BB
    J Immunol; 2016 Jun; 196(12):4839-47. PubMed ID: 27260767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential.
    Saus E; Iraola-Guzmán S; Willis JR; Brunet-Vega A; Gabaldón T
    Mol Aspects Med; 2019 Oct; 69():93-106. PubMed ID: 31082399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The human gut microbiota: Interactions with the host and dysfunctions].
    Lepage P
    Rev Mal Respir; 2017 Dec; 34(10):1085-1090. PubMed ID: 28506730
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease.
    Pickard JM; Zeng MY; Caruso R; Núñez G
    Immunol Rev; 2017 Sep; 279(1):70-89. PubMed ID: 28856738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of the microbiota on the host immune system.
    Karczewski J; Poniedziałek B; Adamski Z; Rzymski P
    Autoimmunity; 2014 Dec; 47(8):494-504. PubMed ID: 25019177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting the complex interactions between microbiota, host epithelial and immune cells in inflammatory bowel disease.
    Hirata Y; Ihara S; Koike K
    Pharmacol Res; 2016 Nov; 113(Pt A):574-584. PubMed ID: 27702681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gut-lung axis: The microbial contributions and clinical implications.
    He Y; Wen Q; Yao F; Xu D; Huang Y; Wang J
    Crit Rev Microbiol; 2017 Feb; 43(1):81-95. PubMed ID: 27781554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of gut microbiota in cardiovascular diseases.
    Novakovic M; Rout A; Kingsley T; Kirchoff R; Singh A; Verma V; Kant R; Chaudhary R
    World J Cardiol; 2020 Apr; 12(4):110-122. PubMed ID: 32431782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Influence of the Microbiome on Early-Life Severe Viral Lower Respiratory Infections and Asthma-Food for Thought?
    Lynch JP; Sikder MA; Curren BF; Werder RB; Simpson J; Cuív PÓ; Dennis PG; Everard ML; Phipps S
    Front Immunol; 2017; 8():156. PubMed ID: 28261214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How the microbiota shapes rheumatic diseases.
    Van de Wiele T; Van Praet JT; Marzorati M; Drennan MB; Elewaut D
    Nat Rev Rheumatol; 2016 Jul; 12(7):398-411. PubMed ID: 27305853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pulmonary microbiome: challenges of a new paradigm.
    Costa AN; Costa FMD; Campos SV; Salles RK; Athanazio RA
    J Bras Pneumol; 2018; 44(5):424-432. PubMed ID: 30066739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mast cells at the crossroads of microbiota and IBD.
    De Zuani M; Dal Secco C; Frossi B
    Eur J Immunol; 2018 Dec; 48(12):1929-1937. PubMed ID: 30411335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gut Microbiota: From Microorganisms to Metabolic Organ Influencing Obesity.
    Stephens RW; Arhire L; Covasa M
    Obesity (Silver Spring); 2018 May; 26(5):801-809. PubMed ID: 29687647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms by Which the Gut Microbiota Influences Cytokine Production and Modulates Host Inflammatory Responses.
    Mendes V; Galvão I; Vieira AT
    J Interferon Cytokine Res; 2019 Jul; 39(7):393-409. PubMed ID: 31013453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.